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Abstract 
T h e   a i m   o f   t h i s   s t u d y   w a s   t o   determine the feasibility and safety of high intensity focused 
ultrasound’s (HIFU) in pancreatic diseases. Twelve pigs were divided into three groups. The 
pancreases of pigs in Group A were ablated directly with HIFU, but those in Group B and C 
ablated by extracorporeal HIFU. The pigs in Group C were sacrificed at d a y   7   a f t e r   H I F U .  
Serological  parameters  were  determined  pre-operation  and  post-operation.  The  entire 
pancreas was removed for histological examination. Each animal tolerate the HIFU ablation 
well. The complete necrosis was observed in targeted regions. The margins of the necrotic 
regions were clearly delineated from the surrounding normal tissues. Infiltration of inflam-
matory cells and phorocytosis on the boundary were found in group C. Blood and urine 
amylase levels were relatively steady a f t e r   H I F U .   N o   a c u t e   p a n c r e a t i t i s   o r   s e v e r e   c o m p l i c a-
tions occurred. In conclusion, H I F U   a b l a t i o n   o n   t h e   p a n c r e a s   w a s   s a f e   a n d   e f f e c t i v e   i n   e x p e-
rimental pigs. 
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INTRODUCTION 
Pancreatic  cancer  is  one  of  the  most  common 
malignancies  of  the  digestive  system  and  has  poor 
prognosis.  The  incidence  of  pancreatic  cancer  is 
gradually increasing worldwide [1].  Currently,  sur-
gical intervention remains the only potential curative 
t h e r a p y ;   h o w e v e r ,   t h e   m a j o r i t y   o f   pancreatic  cancers 
are not suitable for surgical resection due to the ad-
vanced stage. Therefore, non-operative therapies are 
alternatives for patients with pancreatic cancer at the 
advanced stage [2].  
 High  intensity  focused  ultrasound  (HIFU) is  a 
minimally invasive technique  for  the  regional treat-
ment of solid tumors. It can transmit external acoustic 
energy into the body and selectively produce target 
lesions  without  damaging  the  intervening  tissues. 
Lynn et al first applied HIFU in animal study in 1942 
[3].  During  the  1950s  and  1960s,  numerous  studies 
have been conducted to investigate the role of HIFU 
in treating human neurological disorders [2, 4]. At the 
same time, the characteristics of HIFU and its effects 
on experimental tumors have also been explored. In 
Europe and Japan, HIFU has been used in the clinical 
treatment of prostate hypertrophy. In 1956, HIFU was 
first  introduced to the treatment of human solid car-
cinomas  [4].  The  treatment  of  hepatocellular  carci-
noma  (HCC)  with  HIFU  was approved in China in 
1 9 9 9   a n d   i s   c u r r e n t l y   b e i n g   p e r f o r m e d   i n   m a n y   c e n-
ters [5, 6]. To date, HIFU has been used to treat many 
tumours of solid organs including HCC,  renal  carci-
noma, sarcomas, urinary bladder tumors and prostate 
carcinoma [7-10]. Some nonrandomized studies using 




c r e a t i c   c a n c e r   ( p r o l o n g a t i o n   o f   l i f e   a n d   r e l i e f   o f   c a r c i-
noma-related pain) have been reported [11,  12]. Be-
c a u s e   p a n c r e a t i c   i n j u r y   m a y   r e s u l t   i n   s e v e r e   p a n-
creatitis and other serious complications,   t h e   s a f e t y   o f  
HIFU  is  an  important  concern.  O n l y   a   f e w   experi-
mental data have been reported with pathologic evi-
dence for its efficacy and safety. To evaluate the rela-
tionship between HIFU energy and pancreas histol-
ogy,  a  preclinical  in  vivo  study  was  conducted  in 
swine  demonstrating  the  feasibility  and  safety  of 
HIFU for pancreas ablation [13]. In the present study, 
w e   a i m e d   t o   c o n f i r m   t h e   f e a s i b i l i t y   a n d   s a f e t y   o f   H I F U  
a b l a t i o n   t o   t h e   p a n c r e a s   o f   p i g s   u s i n g   m i c r o s c o p y   t o  
provide  additional  evidence  to  support  its  clinical 
application.  
MATERIALS AND METHODS 
Animals  
Twelve  mongrel  pigs  (both  sexes)  weighing 
24-26 kg were purchased from t h e   A n i m a l   C e n t e r   o f  
Guangzhou  Medical  College  (Guangzhou  City, 
Guangdong Province, China). The pigs were divided 
r a n d o m l y   i n t o   t h r e e   g r o u p s   ( n = 4 per group). In the 
Group A, laparotomy was performed,   a n d   t h e   p a n-
creas was ablated directly through the surf a c e   o f   t h e  
pancreas  with  an  HIFU transducer.  In  the  Group B 
and Gr o u p   C ,   e x t r a c o r p o r e a l   H I F U   a b l a t i o n   t h e   p a n-
creas was performed through intact skin. Animals in 
Group  A  and  B  were  sacrificed  immediately  after 
HIFU procedures, whereas those in Group C at day 7 
after HIFU. Experiments and animal care were carried 
o u t   i n   c o m p l i a n c e   w i t h   t h e   g u i d e   f o r   t h e   c a r e   a n d   u s e  
o f   l a b o r a t o r y   a n i m a l s   f r o m   t h e   M i n i s t r y   o f   S c i e n c e  
and Technology of the People’s Republic of China.  
Instruments 
H I F U   a b l a t i o n   w a s   p e r f o r m e d   w i t h   a   H I F U  tu-
m o r   t h e r a p y   s y s t e m   ( Model  JC  type,  Chongqing 
HaifuTech Co., Ltd, Chongqing City, China). The in-
strument was composed of three parts: a firing system 
l o c a t e d   i n   a   d e g a s s e d   w a t e r   t a n k ,   a n   i m a g i n g   s y s t e m  
consisting  of  an  ultrasound  scanner  coupled with  a 
sterotaxic localizing arm, and a computer-controlled 
s y s t e m   f o r   t h e   f i r i n g   s e q u e n c e   a n d   t h e   m o v e m e n t   o f  
the firing head in three dimensions.  
 Focused ultrasound was produced with a 12-cm 
diameter piezoelectric ceramic transducer. The system 
was  operated  using  one  of  the  several  therapeutic 
transducers with the focal length of 90 to 160 mm. For 
each focal length, there is   a   c h o i c e   o f   t w o   t r a n s d u c e r s  
depending  on  the  target  depth:  one  operates  at 0.8 
MHz w i t h   1 3 5 -mm focal length and the other operates 
at 1.6 MHz with  90-mm  focal  length. The  choice  of 
transducers  depends  on  the  depth  of  target  lesion, 
with  th e   m o s t   c o m m o n l y   u s e d   p a r a m e t e r s   i n   t h i s  
s t u d y   w e r e   0 . 8 -MHz  operating  frequency  and 
135-mm focal length. In the centre of the transducer, 
there is a 3.5- to 5.0-MHz diagnostic ultrasound (US) 
imaging probe which is used as the real-time imaging 
unit of the system,   g u i d i n g   t h e   t a r g e t   t i s s u e   v o l u m e ,  
monitoring the energy deposition and the therapeutic 
effect, and also controlling the US exposure based on 
the feedback digital data from the ultrasonograms in 
the  process  of  HIFU  treatment.  The  therapeutic 
transducer and diagnostic imaging device were inte-
grated  into  one  transducer,  and  their  beams  were 
completely  overlaid  each  other  in  the  longitudinal 
diretion. The integrated transducer is moved by elec-
t r i c   m o t o r s   a n d   c a n   b e   m o v e d   s m o o t h l y   i n   s i x   d i r e c-
tions, including three orthogonal directions (x, y, z), 
rotation along the ultrasound beam axis (θ), and rota-
t i o n   a l o n g   t h e   l o n g   o r   s h o r t   a x i s   o f   t h e   b e d   ( γ ,  φ) . 
T h r o u g h   c o m p u t e r   c o n t r o l ,   t h e   i m a g i n g   p r o b e   w a s  
placed either against the skin or at a distance from the 
skin  in  water  for  pre-treatment  imaging.  The  inte-
g r a t e d   t r a n s d u c e r   w a s   m o u n t e d   i n   a   d e g a s s e d   w a t e r  
reservoir with the ultrasound beam directed upward. 
The  ultrasound  beam  of  the  therapeutic  transducer 
and the imaging probe overlapped completely, so that 
the  longitudinal  axis  of  the  high-intensity  focused 
ultrasound beam is in the two-dimensional US imag-
ing  plane.  A  calibrated  polyvinylidene  difluoride 
membrane hydrophone with a spot diameter of 0.5 
mm was used to map the acoustic pressure field of the 
focused transducer at focal peak intensities of 200~300 
W/cm2 [2].   T h e   f o c a l   r e g i o n   w a s   c i g a r   s h a p e d ,   w i t h  
d i m e n s i o n s   o f   9 . 8   m m   a l o n g   t h e   b e a m   a x i s   a n d  1.3 
mm in the transverse direction. The absorbing target 
method was used to measure the total acoustic power 
output in degassed water at 21°C [6, 14]. 
HIFU procedure  
The pigs were fasted for 72 h and then adminis-
tered  folium  sennae  tea  to  clean  the  intestinal  tract. 
T h e   s k i n   c o v e r i n g   t h e   H I F U   t a r g e t   a r e a   w a s   s h a v e d ,  
washed with degassed water, and defatted with 75% 
alcohol solution before the procedure. Catheters were 
inserted into ear veins and ketamine was infused (50 
mg/h) for anesthesia. Diazepam was administered as 
needed.  
The HIFU ablation procedure complies with the 
guidance of the National Standard of China and was 
described in detail previously [6, 15, 16, 17]. In Group 
A, a laparotomy was performed and the pancreas was 
exposed followed by direct ablation of the head of the 
pancreas with  a  HIFU transducer. In Group B and C, 
the animals were fixed in  a prone position. A rubber 




integrated  transducer  and  the  skin in  order to well 
locate  the  target  region.  The  real-time  US  imaging 
device was used to locate the head of pancreas as the 
pre-designed target region. The spatial volumes of the 
t a r g e t   r e g i o n s   i n   t h e   X ,   Y  and Z axes were 10×10×10 
mm. There were three slices i n   t h e   Z   a x e s ,   s o   t h e   i n-
terval distance between adjacent slices was 5 mm. The 
monitoring system of the therapeutic transducer was 
switched  on  for  ablation  (power,  220 W;  frequency, 
1.6MHz [Group  A]  and  0.8  MHz [Gr o u p   B   a n d   C ]; 
focal length, 90 mm [Group A] and 135 mm [Group B 
and  C]).  A   f o c u s e d   U S   b e a m   w a s   m e c h a n i c a l l y  
s c a n n e d   c o n t i n u o u s l y   a t   a   s p e e d   o f   0 . 5   t o   3   m m / s .   T h e  
treatment focus was moved from points to lines, then 
to  planes  and  thereafter  volume  (total  time  of  abla-
tion:  145  s). Eventually the entire target region  was 
c o v e r e d   b y   H I F U ,   l e a d i n g   t h e   c o a g u l a t i o n   n e c r o s i s   o f  
the  whole  target  regions.  During  the  therapeutic 
process, real-time estimation of the therapeutic effect 
w a s   c a r r i e d   o u t   b y   t h e   c o m p u t e r   s y s t e m   t h r o u g h   t h e  
g r a p h i c   c h a n g e s   i n   t he target field and the hyperecho 
of the tissues. Blood pressure, pulse, respiration, and 
blood  oxygen  saturation  were  monitored  during 
HIFU treatment. 
Animal care 
The animals in Group A and B were sacrificed 
immediately after HIFU, and the whole pancreas was 
removed  for  histological  examination.  After  HIFU 
treatment, the animals in Group C were fasted for 1 to 
4 days until blood and urine amylase levels reached a 
normal level when these  pig intravenously received 
penicillin (4.8×106 units), gentamycin (1.6×105 units), 
and ranitidine (100g) in  5% glucose  saline (1500 ml) 
plus 10% glucose solution (1000 ml) daily. Then, they 
were  allowed  free  access  to a standard liquid diet. 
Vital  signs  and ultrasound-induced skin burns were 
monitored.  Blood  and  urine samples were collected 
and leukocyte numbers, and levels of blood amylase, 
glucose,  aspartate  aminotransferase  (AST),  urea  ni-
trogen (BUN) and total bilirubin were determined by 
Automatic  Biochemical  Analyzer (VITROS 250,  Or-
tho-clinical  diagnostics,  Inc. ,   N J ,   U S A )   b e f o r e   t h e  
HIFU procedure and at d a y s   1 ,   2 ,   3 ,   5  and 7   p o s t -HIFU 
procedure. At day 7, the animals were sacrificed, and 
the  whole  pancreas  was  removed  for  histological 
examination. 
Histological examination 
The  pancreas  was  stained  with  1% 
2,3,5-triphenyltetrazolium chloride (TTC) solution for 
5 to 7 min, and  then washed with water. Gross  ob-
servations including the appearance, size and shape 
of pancreas were recorded. The necrosis volume was 
calculated  as  follow:  4/3π(A/2) × (B/2) × (C/2), 
where A, B,   a n d   C represent the three perpendicularly 
orientated diameters of the tumor. Then, the pancreas 
samples were fixed in 40 g/L formaldehyde salution, 
embedded in paraffin and stained with hematoxylin 
and eosin (H&E) for light microscopy (Olympus BH2, 
Olympus Corporation, Tokyo, Japan). 11P a r t   o f   s am-
ples were processed for  and evaluated by transmis-
sion  electron  microscopy  (JEM-100CX,  JEOL  Ltd. 
Tokyo, Japan). 
Statistical analysis  
Data were expressed as means ± standard devi-
ation  (SD),  and  comparisons  were  performed  with 
Wilcoxon rank sum test. All statistical analyses were 
carried  out  using  SPSS  software  12.5  for  Windows 
(SPSS Inc., Chicago, IL, USA).  
RESULTS 
Survival of animals 
Vital signs including blood pleasure, pulse, res-
piration, and blood oxygen saturation of all animals 
were stable during and after HIFU, demonstrating the 
pigs tolerated H I F U   t h e r a p y .   T h e   a n i m a l s   i n   Group C 
recovered  smoothly  after  HIFU  treatment  and  sur-
vived for at least 7  days. Transient fatigue occurred 
and lasted for 1 to 3 days; however, no severe com-
plications such as acute pancreatitis were observed. 
Mild skin burns at the HIFU sites were noted in two 
pigs in Group B and C.  
Pathological presentations 
After  HIFU  therapy,  pale  coagulation  necrosis 
was  easily  identified  in  pancreas  samples  of  all 
groups. Normal pancreatic tissues were red, whereas 
tissues of  coagulation necrosis were white after TTC 
staining. In Group A and B, there was a sharp boun-
d a r y   b e t w e e n   t h e   H I F U   n e c r o s i s   a n d   v i a b l e   t i s s u e  
(Fig. 1). In Group C, the treated tissues were shrunk 
and had clear boundaries at day 7 post-HIFU proce-
dure. The irregularly-shaped necrotic regions were all 
smaller than 1 cm3, a theoretical necrosis volume. No 
significant  difference  in  the  necrotic  tissue  volume 
was observed among the three groups (Table 1), and 
thermolesions  to  intervening  tissue  were  never  ob-
served. 
Table 1.  HIFU therapeutic parameters 






Distance between skin 
and ablate foci (mm) 
Group A  220  145  212.5 ± 25.3   
Group B   220  145  189.0 ± 39.8*  47.2 ± 2.8△ 
Group C  220  145  198.0 ± 25.5*  47.5±2.9△ 
W, watt.  Data are expressed as mean ± SD; *P > 0.05; △P > 0.05. 





Figure 1. TTC staining of pancreas at  day 7 after HIFU. 
Coagulation necrosis (black arrow) was obvious and white 
arrow showed the normal pancreas. The boundary  was 
clear. 
 
Under light microscope, the following characte-
r i s t i c s   o f   n e c r o t i c   r e g i o n s   i n   t h e   p a n c r e a s   o f   Group A 
a n d   B   w e r e   present:  karyopycnosis  and  nuclear 
fragmentation were observed in most of cells,  and  a 
sharp boundary between the normal tissue and target 
zones.  Vascular  proliferation  and  inflammatory 
hyperplasia  were  not  evident  (Fig.  2).  Pancreatic 
samples  in  Group  C  at  day 7 post-HIFU  exhibited 
different features from those in Group A and B: target 
tissues were destroyed with necrotic cells and nuclear 
d e b r i s   w a s   o b s e r v e d   i n   t h e   n e c r o t i c   r e g i o n s .   T h e   p a n-
creatic cells were amorphous, irregular, and bulky. A 
narrow  region  with  inflammatory  cell  infiltration, 
consisting primarily of lymphocytes  and  monocytes 
sometimes  w i t h   s m a l l   n u m b e r   o f   e o s i n o c y t e s ,   w e r e  
seen between the necrotic and normal zones. In addi-
tion,  hyperplasia  of  fibroblasts  and  collagen  fibers 
were also noted in some regions (Fig. 3).  
 
Figure  2. Presentations of pancreas in Group A  and B 
under light microscope after HIFU (H&E, ×200). A apparent 
boundary  was  seen  between  normal  (A)  and  target  (B) 
tissues (red line). Scale bar =20 μm. 
 
Figure 3.  Presentations of pancreas   i n   G roup C under 
light microscope (H&E ×200), at day 7 after HIFU ablation. 
Infiltration of inflammatory  cells and collagen fibers were 
observed and evident boundary between normal (A) and 
target (B) tissue was noted. Scale bar =20 μm. 
 
Table 2.  Biochemistry results pre- and post-HIFU in group C 
  Pre-HIFU  Day 0  Day 1  Day 2  Day 3  Day 5  Day 7 
Urine               
Amylas (U/L)  80.3±26.1  78.4±20.1  134.8±33.5  127.5±26.7  111.5±16.6  106.5±16.8  92.8±20.6 
Blood               
Amylas (U/L)  564.6±115.9  539.1±157.8  759.5±127.6  780.5±76.4  667.5±137.2  542.5±173.5  587.5±148.4 
Glucose (mmol/L)  4.29±1.43  4.76±1.11  4.48±1.09  4.40±0.65  4.63±1.47  4.95±1.57  4.68 ±1.54 
Total bilirubin (μmol/L)  14.4±6.1  15.3 ±6.3  16.9±4.9  19.9±4.4  12.1±3.1  12.2±3.2  11.2±2.5 
Leukocyte (×109/L)  12.9±1.96  13.5±1.56  13.1±1.35  13.4±1.74  12.1±1.63  12.5±1.57  14.0±1.48 
AST (mmol/L)  71.5±29.9  76.9±32.2±  78.3±21.3  59.5±27.3  54.2±31.1  99.0±35.5  49.8±38.4 
BUN (mmol/L)  3.24±0.89  3.99±1.71  4.30±1.60  3.09±2.19  4.25±1.09  3.42±1.21  3.60±0.80 
Data are presented as means±SD; All dataP > 0.05 vs pre-HIFU.  





Under  a transmission  electron  microscope,  the 
following characteristics were observed in the necrotic 
regions  o f   t h e   G roup  A  and  Group  B:  the  nuclear 
m e m b r a n e   h a d   c o l l a p s e d   a n d   c h r o m a t i n   w a s   l o c a-
lized  along  the  nuclear  margin.  Endochylema  was 
v a c u o l a t e d ,   a n d   m i t o c h o n d r i a   s w e l l e d   t o   a   c i r c u l a r  
s h a p e   w i t h   a   c l e a r  matrix and short or  disappeared 
cristae,  which  were  vacuolar  appearances.  Smooth 
and rough endoplasmic reticulum expanded and be-
came  vacuolar  or  fragmented  (Fig. 4).  At  7  day 
post-HIFU, in Group  C,  the  cell membrane was com-
pletely destroyed and collapsed. The ultrastructures 
c o u l d   n o t   b e   i d e n t i f i e d ,   a n d   a p o p t o t i c   b o d i e s   w e r e  
observed (Fig. 5).  
 
Figure 4.    Presentations of pancreas in Group A  and B 
under  transmission  electron  microscope  (×10000). 
Chromatin margination (A), endochylema vacuolation (B), 
smooth endoplasmic reticulum expansion (C) and widened 
nuclear envelope (D) were observed. 
 
Figure 5.    Presentations of pancreas   i n   G roup C under 
transmission electron microscope (×10000) at day 7 after 
HIFU. The cell membrane was completely destroyed, and 
ultrastructures could not be identified.  
Biochemistry parameters  
In the present  study,  the  amylase levels in the 
serum and urine were increased in the first 3 days and 
the first 5 days after HIFU ablation, respectively. But 
no significant difference was observed. Furthermore, 
the amylase levels   w e r e   n o t   3   t i m e s   h i g h e r   t h a n   t h a t  
before  HIFU  ablation.  Moreover,  there  were  not 
marked differences in the levels of other serum pa-
rameters between before and after HIFU ablation.  
DISCUSSION 
T h e   i d e a l   t r e a t m e n t   o f   a   l o c a l i z e d   c a n c e r   s h o u l d  
achieve complete tumor cell death without damage to 
the  adjacent  tissues.  HIFU  is  a  minimally  invasive 
technique that may induce complete coagulation ne-
crosis of target tissues through intact skin. HIFU may 
be  precisely  focused on  a  tumour  in t h e   b o d y .   T h e  
acoustic  energy  passes  through  the  intervening  tis-
sues to a tightly focused target region. The  high  po-
wered focused beams employed are generated from 
sources placed either outside the body (for treatment 
of tumors of the liver, kidney, breast, uterus, pancreas 
a n d   b o n e )   o r   i n   t h e   r e c t u m   ( f o r   t r e a t m e n t   o f   t h e   p r o s-
tate), and are designed to enable rapid heating of a 
target tissue volume, while leaving tissue in the ul-
trasound propagation path relatively unaffected [18]. 
The mechanisms of HIFU ablation are primarily coa-
gulation necrosis, acoustic  cavitation,  and  apoptosis 
induced by hyperthermia [7, 19, 20, 21]. The rapid rate 
of energy deposition generates a rapid temperature 
increase  (65oC–100oC),  which  results  in  irreversible 
cell death, with surrounding areas remaining largely 
unheated.  In  addition,  HIFU  can  also  activate  the 
immune response [22, 23]. The minimal invasiveness 
and accurate targeting w i t h   a   r e a l -time US guide al-
low HIFU to precisely ablate lesions of large size, ir-
regular  shape, and even multi-modularity. A  major 
a d v a n t a g e   o f   H I F U   o v e r   o t h e r thermal ablation tech-
niques is that there is no necessity for the transcuta-
n e o u s   i n s e r t i o n   o f   p r o b e s   i n t o   t h e   t a r g e t   t i s s u e ,  which 
is  not  achievable  with  other  conventional  ablation 
techniques including percutaneous ethanol injection 
(PEI),  radiofrequency (RF), interstitial laser coagula-
t i o n   ( I L C ) ,   a n d   c r y o t h e r a p y  [7, 20, 21]. Because HIFU 
is  minimally  invasive  and  accurate,  and  possesses 
real-time  targeting,  it  provides  patients  with  a  new 
therapeutic option with less pain and damage to the 
splanchnic functions and fast recovery. 
The  pancreas,  a  deep  abdominal  organ  sur-
rounded by complicated anatomic structures, has  an 
exocrine  function  and  is  sensitive  to  hyperthermia, 
which can result in the rupture of the pancreatic ducts 




c a n   d i g e s t   t h e   p a n c r e a s   i t s e l f ,   c a u s i n g   s e v e r e   c o m p l i-
cations such as traumatic pancreatitis or pancreato-
genic peritonitis. Thus, safety remains the main con-
cern  of  any  medical  intervention  of  the  pancreatic 
diseases.  
A  previous  preclinical  in vivo  study  in  swine 
demonstrated  the  feasibility  and  safety  of HIFU  for 
pancreas  ablation;  however,  histological  assessment 
w a s   p e r f o r m e d   o n l y   b y   l i g h t   m i c r o s c o p y  [13].   T o   o u r  
knowledge, in the present study,   w e   f o r  the first time 
used both light microscopy and transmission electron 
microscopy to determine the effects of HIFU on the 
pancreas. The histological presentations  under  light 
and transmission electron microscopes confirmed the 
efficacy  and  safety  of  HIFU  by  revealing  complete 
necrosis only within the target regions and with clear 
boundary; the adjacent tissues were normal. Coagu-
lation  necrosis  is  characterized  by  dehydration  and 
protein coagulation while the structural outline is still 
preserved for a long time. The mechanism of coagu-
lation  necrosis  is  still  unclear.  Lysosomal  enzymes 
play no role in t h e   p r o c e s s   o f   c oagulation  necrosis, 
because the tissues have a small amount of lysosomes, 
or  the  lysosomal  enzymes  are  also  damaged  under 
this circumstance. Acute pancreatitis is characterized 
by liquefaction necrosis, and lysosomal enzymes play 
a n   i m p o r t a n t   r o l e   i n   t h e   d e v e l o p m e n t   a n d   p r o g r e s s i o n  
of pancreatitis. In present study, transmission electron 
microscopy was performed to observe the cell  mem-
brane and  ultrastructures  of  cells. Results  confirmed 
that,  after  HIFU  ablation,  coagulation  necrosis  oc-
curred in the pancreas, and cell membrane, lysosomes 
and other organelles were intact. Therefore, a  variety 
of  digestive  enzymes will not be released  from  cells, 
avoiding  the  liquefaction  necrosis  and  subsequent 
pancreatitis.  In  addition,  the  rapid  temperature  in-
crease  by  HIFU  in  pancreas  deactivates  pancreatic 
enzymes, and then prevents pancreatitis [24,  25]. In 
our study, light  microscopy displayed abundant va-
c u o l e s   o f   v a r i o u s   s i z e s   i n   t h e   c y t o p l a s m   a n d   c h r o m a-
tin margins and karyopyknosis in some cells. Electron 
microscopic examination revealed further details such 
as  presence of karyopyknosis and chromatin margi-
nation  in  some  cells,  intercellular  space  widening, 
apoptotic bodies with high electron-density and nu-
merous vacuoles  of  different sizes confirming the ca-
vitation of HIFU.  
D u r i n g   H I F U ,   v i t a l   s i g n s   o f   a l l   p i g s   w e r e   s t a b l e . 
After  HIFU,  these  anim a l s   r e t u r n e d   t o   n o r m a l   d i e t  
and  recovered  rapidly.  In  the  present  study,  the 
amylase levels in the serum and urine were increased 
i n   t h e   f i r s t   3   d a y s   a n d   t h e   f i r s t   5   d a y s   a f t e r   H I F U   a b-
lation, respectively. But no significant difference was 
observed. Furthermore, the amylase levels were not 3 
times  higher  than  that  before  HIFU  ablation,  which 
w a s   c o n s i s t e n t   w i t h   w h a t   G o l d b e r g   e t   a l .,  reported 
[26].   T h e r e f o r e ,   H I F U   a p p e a r s   t o   b e   s u i t a b l e  for  abla-
tion of pancreatic tumors.  
P a n c r e a t i c   c a n c e r   i s   a   t y p e   o f   t u m o r s  with poor 
blood supply. Blood vessels in the pancreatic tumors 
are thin without branches, which helps thermothera-
pies  achieve  good  efficacy  due  to  limited  thermal 
diffusion [2].   H I F U   i s   a l s o   a b l e   t o   collapse blood ves-
s e l s   s m a l l e r   t h a n   2   m m   i n   d i a m e t e r   a n d   block blood 
flow to the  tumors [27]. Our results were consistent 
with the findings of Hwang et al [13]. 
Acoustic energy decreases gradually as it prop-
agates through the intervening tissues. Anatomically 
the pancreas lies in deep abdomen and is surrounded 
by  many  important  anatomic  structures.  The 
gas-containing organs s u c h   a s   the gastrointestinal (GI) 
tracts are poor transmitters of US beam which affects 
HIFU targeting and ablation [13].   I n   o u r   p i l o t   s t u d y ,  
damage to the adjacent tissues was observed due to 
g a s   i n   t h e   G I   t r a c t s .   I n the present study, we chose 
s m a l l   m o n g r e l   p i g s   w e i g h i n g   o n l y   a b o u t   2 5   k g   a n d  
c a r e f u l l y   e m p t i e d   t h e   G I   t r a c t   b y   f a s t i n g   a n d   s e n-
na-induced  catharsis  before  HIFU.  In  addition,  a 
r u b b e r   b a g   f i l l e d   w i t h   d e g a s s e d   w a t e r   w a s   placed 
between the integrated transducer and skin. In Group 
B and C, a water bag with proper pressure was able to 
expel the intervening tissues and shorten the distance 
between the transducer and the pancreas. The necrotic 
volumes in Group A were somewhat larger than those 
in Group B and C  (but not significant), probably due 
to the presence of gas  ex vivo.   I n   t h i s   s t u d y ,   t h e   v o-
lumes  of  coagulation  necrosis  in  all  samples  were 
within an ideal range. The actual biological focal re-
gions might not be necessarily equal to physical focus 
regions in HIFU treatment [14].  
In  the  present  study,  we  demonstrated  that 
HIFU is effective and safe for the a b l a t i o n   o f   t h e   p a n-
creas in a   s w i n e   m o d e l .   O u r   r e s u l t s   p r o v i d e   e v i d e n c e  
supporting the clinical application of HIFU in patients 
with pancreatic cancer. 
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